The use of Nutraceuticals as Mono- or Adjuvant Therapy to Pharmacotherapies in Major Depressive Disorder

References (51)

1. 1 New approaches to antidepressant drug discovery: beyond monoamines [DOI]
2. 2 A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression [DOI]
3. 3 Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders [DOI]
4. 4 Current advances and trends in the treatment of depression [DOI]
5. 5 Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role [DOI]
6. 6 Fish consumption and major depression [DOI]
7. 7 Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies [DOI]
8. 8 Monoamine neurocircuitry in depression and strategies for new treatments [DOI]
9. 9 Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients [DOI]
10. 10 A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression [DOI]
11. 11 Homocysteine and folate metabolism in depression [DOI]
12. 12 Understanding nutrition, depression and mental illnesses [DOI]
13. 13 Enhancement of recovery from psychiatric illness by methylfolate [DOI]
14. 14 Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed mood [DOI]
15. 15 Quality of life assessments in major depressive disorder: a review of the literature [DOI]
16. 16 Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan [DOI]
17. 17 Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis [DOI]
18. 18 Nutritional therapies for mental disorders [DOI]
19. 19 The Molecular Neurobiology of Depression [DOI]
20. 20 Effects of n–3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials [DOI]
21. 21 Cellular and molecular mechanisms in the long-term action of antidepressants. [DOI]
22. 22 Vitamin B12 Supplementation in Treating Major Depressive Disorder: A Randomized Controlled Trial [DOI]
23. 23 The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo [DOI]
24. 24 How Fast Are Antidepressants? [DOI]
25. 25 The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine [DOI]
26. 26 High vitamin B12 level and good treatment outcome may be associated in major depressive disorder [DOI]
27. 27 Mood effects of the amino acids tryptophan and tyrosine [DOI]
28. 28 S-adenosylmethionine (SAMe) as treatment for depression: a systematic review.
29. 29 Folate and Unipolar Depression [DOI]
30. 30 Folate, Vitamin B12, Homocysteine, and Depressive Symptoms in a Population Sample of Older Chinese Adults [DOI]
31. 31 Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials [DOI]
32. 32 Dietary intake of B6-9-12 vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study [DOI]
33. 33 Use of neurotransmitter precursors for treatment of depression.
34. 34 L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive Episode.
35. 35 The Role of L-Methylfolate in Depressive Disorders [DOI]
36. 36 Behavioral effects of dietary neurotransmitter precursors: Basic and clinical aspects [DOI]
37. 37 Measuring quality of life in depression [DOI]
38. 38 Are Tryptophan and 5-Hydroxytryptophan Effective Treatments for Depression? A Meta-Analysis [DOI]
39. 39 Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements.
40. 40 Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis.
41. 41 Tyrosine for depression: a double-blind trial [DOI]
42. 42 Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
43. 43 Rapid measurement of free amino acids in serum and CSF using high-performance liquid chromatography [DOI]
44. 44 D-phenylalanine in endogenous depression [DOI]
45. 45 dl-Phenylalanine versus imipramine: A double-blind controlled study [DOI]
46. 46 Enhancement of recovery from psychiatric illness by methylfolate [DOI]
47. 47 Herbal Remedies and Nutraceuticals as Augmentation or Adjunct for Mood and Anxiety Disorders: Evidence for Benefit and Risk [DOI]
48. 48 Diagnostic and Statistical Manual of Mental Disorders [DOI]
49. 49 Protein and amino acid requirements in human nutrition.
50. 50 Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,, [DOI]
51. 51 A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression [DOI]

Cited by 0

No indexed citations yet.

Related research

• Use of Omega-3 Supplements for the Amelioration of Glucose Levels and Lipid Profile Parameters in Female University: A Randomized Control Study — shares topic coverage
• Can Leafy Vegetable Source of Omega-3 fatty Acids Ameliorate Acute Intestinal Inflammation Induced in Mice? A Case study of Purslane (Portulaca oleracea) — shares topic coverage
• The Functional Nutrients of Flaxseed and Their Effect on Human Health: A Review — shares topic coverage
• Risk-Benefit Assessment of Cold-Smoked Salmon: Microbial Risk versus Nutritional Benefit — shares topic coverage
• Nutritional Composition, Bioactive Properties, and Agri-Food Applications of Walnuts and Pomegranate Fruits — shares topic coverage